Sean Kendall

Partner, ARCH Venture Partners

London, England

About

Male

Sean Kendall is based out of London, England, and is the Partner of ARCH Venture Partners and Board Member of Syndex Bio. Sean Kendall attended Stanford University. Sean Kendall has received the Presidential Green Chemistry Challenge Award.

Experience

ARCH Venture Partners

Partner · 2022 – present

View →

31Chicago, Illinois, United StatesFinance · Financial Services

Board Member · Syndex Bio
2026 – present
Board Member · Moleculent

Education

Stanford University · MS, Chemical Engineering
– 2007
Stanford University · BS, Chemical Engineering
2002

Headlines from Google News. Social posts load from the platform only when you open a tab.

Lightcast: $27 Million Financing To Accelerate Commercial Launch Of Envisia Single-Cell Platform
pulse2.com · Apr 15
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform
Business Wire · Apr 14
Single-cell specialist Lightcast raises $27m to take haul to date to $122.5m
Business Weekly · Apr 13
Syndex Bio unveils mcPCR technology at AGBT 2026 following $15.5 M seed financing
News-Medical · Feb 23
Swedish startup's $26 million Series A funding marks a turning point in cellular communication mapping
ArcticStartup · Jun 12

People at ARCH Venture Partners

Data from: crunchbase